332 related articles for article (PubMed ID: 34116823)
1. Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.
King Z; Kramer C; Latkin C; Sufrin C
J Subst Abuse Treat; 2021 Jul; 126():108338. PubMed ID: 34116823
[TBL] [Abstract][Full Text] [Related]
2. United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder.
Benck KN; Seide K; Jones AK; Omori M; Rubinstein LB; Beckwith C; Nowotny KM
Drug Alcohol Depend; 2023 Jun; 247():109863. PubMed ID: 37071946
[TBL] [Abstract][Full Text] [Related]
3. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
[TBL] [Abstract][Full Text] [Related]
4. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
[TBL] [Abstract][Full Text] [Related]
5. Assessing provision of MOUD and obstetric care in U.S. jails: A content analysis of policies submitted by 59 jails.
Kao L; Lee C; Parayil T; Kramer C; Sufrin CB
Drug Alcohol Depend; 2023 Jul; 248():109877. PubMed ID: 37244223
[TBL] [Abstract][Full Text] [Related]
6. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
7. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
Brezel ER; Powell T; Fox AD
Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
[TBL] [Abstract][Full Text] [Related]
8. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
[TBL] [Abstract][Full Text] [Related]
9. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
Treitler PC; Enich M; Reeves D; Crystal S
Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
[No Abstract] [Full Text] [Related]
10. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.
Stopka TJ; Rottapel RE; Ferguson WJ; Pivovarova E; Toro-Mejias LD; Friedmann PD; Evans EA
Int J Drug Policy; 2022 Dec; 110():103803. PubMed ID: 35965159
[TBL] [Abstract][Full Text] [Related]
11. Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
Cherian T; Lim S; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Rosner Z; MacDonald R; Lee JD
Drug Alcohol Depend; 2024 Jun; 259():111274. PubMed ID: 38643529
[TBL] [Abstract][Full Text] [Related]
12. "Just fighting for my life to stay alive": a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories.
Hoffman KA; Thompson E; Gaeta Gazzola M; Oberleitner LMS; Eller A; Madden LM; Marcus R; Oberleitner DE; Beitel M; Barry DT
Addict Sci Clin Pract; 2023 Mar; 18(1):16. PubMed ID: 36944998
[TBL] [Abstract][Full Text] [Related]
13. Developing a cascade of care for opioid use disorder among individuals in jail.
Ray B; Victor G; Cason R; Hamameh N; Kubiak S; Zettner C; Dunnigan M; Comartin E; Costello M
J Subst Abuse Treat; 2022 Jul; 138():108751. PubMed ID: 35241352
[TBL] [Abstract][Full Text] [Related]
14. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
Matsumoto A; Santelices C; Evans EA; Pivovarova E; Stopka TJ; Ferguson WJ; Friedmann PD
Int J Drug Policy; 2022 Nov; 109():103823. PubMed ID: 35994938
[TBL] [Abstract][Full Text] [Related]
15. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
Harrington C; Bailey A; Delorme E; Hano S; Evans EA
Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
[No Abstract] [Full Text] [Related]
16. Access to Services for Pregnant People With Opioid Use Disorder in Jails in the United States.
Grella CE; Scott CK; Dennis ML; LaVallee RA
J Correct Health Care; 2023 Aug; 29(4):299-307. PubMed ID: 37252747
[TBL] [Abstract][Full Text] [Related]
17. Medications for opioid use disorder during pregnancy: Access and continuity in a state women's prison facility, 2016-2019.
Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto THM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
Drug Alcohol Depend; 2022 Mar; 232():109308. PubMed ID: 35074696
[TBL] [Abstract][Full Text] [Related]
18. 28-year-old Woman With Opioid Use Disorder Delivers Healthy Baby While in Custody: Addressing Forced Detox.
Gray J; Saia K; Walley AY
J Addict Med; 2019; 13(3):237-240. PubMed ID: 30379779
[TBL] [Abstract][Full Text] [Related]
19. Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail.
Bailey A; Senthilkumar R; Evans EA
J Addict Med; 2023 Sep-Oct 01; 17(5):568-573. PubMed ID: 37788611
[TBL] [Abstract][Full Text] [Related]
20. Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.
McGladrey M; Kelsch J; Lofwall MR; Fanucchi LC; Walsh SL; Oser CB
J Correct Health Care; 2024 Feb; 30(1):3-6. PubMed ID: 38150232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
